5-Methoxy-UTP

5-Methoxy-UTP

Catalog Number:
NNNA373502APE
Mfr. No.:
APE-B8061
Price:
$215
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          5-Methoxy-UTP is an analogue of the naturally occurring uridine triphosphate (UTP). Similar to N1-methylpseudouridine and pseudouridine modifications, 5-methoxyuridine is another common chemical modification used for in vitro mRNA synthesis in order to improve mRNA activity and reduce innate immune responses. Chemical modifications of mRNAs with 5-methoxyuridine, N1-methylpseudouridine and pseudouridine have been shown to significantly improve the expression of enhanced green fluorescent protein (eGFP) in a variety of cell lines, among which 5-methoxyuridine-modified eGFP mRNA is more stable than other eGFP mRNAs. In addition, replacing UTP with 5-methoxy-UTP in Cas9 mRNA has also been reported to reduce innate immune responses, making the broad use of Cas9 possible both in vitro and in vivo.

          1. Li B, Luo X, Dong Y. Effects of Chemically Modified Messenger RNA on Protein Expression. Bioconjugate Chemistry, 2016, 27(3): 849-853.
          2. Vaidyanathan S, Azizian KT, Haque AKMA, et al. Uridine Depletion and Chemical Modification Increase Cas9 mRNA Activity and Reduce Immunogenicity without HPLC Purification. Molecular Therapy - Nucleic Acids, 2018, 12: 530-542.

      • Properties
        • Categories
          A UTP analogue, commonly used for in vitro mRNA synthesis
          Alternative Name
          5-Methoxyuridine-5’-Triphosphate, 5-moUTP; lithium (3,4-dihydroxy-5-(5-methoxy-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl triphosphate
          Molecular Formula
          C10H17N2O16P3 (free acid)
          Molecular Weight
          514.1 (free acid)
          Appearance
          Solution
          Purity
          Purity >95% by AX-HPLC
          Storage
          Store at -20°C or below
          SMILES
          O=C(C(OC)=CN1C2C(O)C(O)C(COP([O-])(OP([O-])(OP([O-])([O-])=O)=O)=O)O2)NC1=O.[Li+].[Li+].[Li+].[Li+]

          * For Research Use Only

      • Reference
        • 1. Denzil Furtado, Christina Cortez-Jugo, et al. "mRNA Treatment Rescues Niemann-Pick Disease Type C1 in Patient Fibroblasts." Mol Pharm. PMID: 36125338
          2. Jingjing Zhang, Yun Li, et al. "Genome-wide CRISPR/Cas9 library screen identifes PCMT1 as a critical driver of ovarian cancer metastasis." J Exp Clin Cancer Res. PMID: 35033172
          3. Jing Lu, Guoliang Lu, et al. "A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice." Cell Res. 2020;1-4. PMID: 32801356

    Note: If you don't receive our verification email, do the following:

  • Copyright © Amerigo Scientific. All rights reserved.